SNCA and Parkinson disease: Several studies have shown that the intracerebral injection of α-synuclein fibrils (e.g., synthetic fibrils or fibrils taken from the brain samples of patients with Parkinson’s disease, dementia with Lewy bodies, or MSA) into transgenic or wild-type mice resulted in neurodegeneration [63,64].